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Abstract
Background & Aims: An increase in CD3+TCRcd+ and a decrease in CD32 intraepithelial lymphocytes (IEL) is a characteristic
flow cytometric pattern of celiac disease (CD) with atrophy. The aim was to evaluate the usefulness of both CD IEL
cytometric pattern and anti-TG2 IgA subepithelial deposit analysis (CD IF pattern) for diagnosing lymphocytic enteritis due
to CD.
Methods: Two-hundred and five patients (144 females) who underwent duodenal biopsy for clinical suspicion of CD and
positive celiac genetics were prospectively included. Fifty had villous atrophy, 70 lymphocytic enteritis, and 85 normal
histology. Eight patients with non-celiac atrophy and 15 with lymphocytic enteritis secondary to Helicobacter pylori acted as
control group. Duodenal biopsies were obtained to assess both CD IEL flow cytometric (complete or incomplete) and IF
patterns.
Results: Sensitivity of IF, and complete and incomplete cytometric patterns for CD diagnosis in patients with positive
serology (Marsh 1+3) was 92%, 85 and 97% respectively, but only the complete cytometric pattern had 100% specificity.
Twelve seropositive and 8 seronegative Marsh 1 patients had a CD diagnosis at inclusion or after gluten free-diet,
respectively. CD cytometric pattern showed a better diagnostic performance than both IF pattern and serology for CD
diagnosis in lymphocytic enteritis at baseline (95% vs 60% vs 60%, p = 0.039).
Conclusions: Analysis of the IEL flow cytometric pattern is a fast, accurate method for identifying CD in the initial diagnostic
biopsy of patients presenting with lymphocytic enteritis, even in seronegative patients, and seems to be better than anti-
TG2 intestinal deposits.
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Introduction
An increase in intraepithelial lymphocyte (IEL) count per 100
enterocytes along villi is a cardinal diagnostic feature of celiac
disease (CD), and it is the only abnormality found in Marsh type 1
lesion.[1,2] However, it is not in itself sufficient for a definitive
diagnosis of CD, as other pathologies may present in the same
manner.[3–5] In this sense, other diagnostic approaches beyond
conventional histology have been introduced for diagnosis of CD
in the presence of a Marsh 1 lesion.[6,7] The recent ESPGHAN
guidelines for diagnosis of CD suggest that in these cases both a
high cd IEL count and the presence of IgA anti-tissue
transglutaminase (anti-TG2) deposits in the mucosa increase the
likelihood of a diagnosis of CD [8].
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Assessment of the density of cd IEL is in general performed with
immunohistochemistry techniques in frozen biopsy sam-
ples.[2,9,10] Flow cytometry is a powerful analytical tool for the
study of small intestinal immune cells and in particular the IEL,
and it has been shown to be of value in the diagnosis of CD with
atrophy, [11–13] and refractory CD.[14,15] The advantages of
flow cytometry are considerable compared to other user-depen-
dent techniques, and results are obtained in a fast, sensitive,
reproducible and objective semi-quantitative way just a few hours
after taking the biopsy sample. It allows the analysis of a greater
number of cells than does immunohistochemistry and yields a
computerized record of the results. Using this technique, an IEL
pattern typical of CD (CD IEL cytometric pattern) was defined,
consisting of both an increase in cd+ IEL and a dramatic decrease
in CD32 IEL (reviewed by Leon F).[11] The cd IEL increase is
not totally specific to CD, since it has occasionally been found in
other conditions such as cow’s milk intolerance, food allergy,
cryptosporidiosis, giardiasis, Sjögren syndrome, and IgA deficien-
cy.[11] However, the increase in cd IEL in a minority of patients
with these conditions tends to be mild and transient.[16] It has
been stated that CD is the only disease in which cd IEL are
increased systematically, permanently, and intensely.[11,17–19]
The concomitant decrease in CD3-IEL provides increased
specificity for the diagnosis of CD.[20] A description of this
CD3-IEL population has been made, showing a CD32 CD7+
CD103+CD45+ phenotype [12,20,21].
CD anti-TG2 specific auto-antibodies are produced at the local
level in the small bowel mucosa. They can be found deposited
below the epithelial basement membrane and around mucosal
capillaries where they may be detected with immunofluorescence
methods in a frozen biopsy sample.[7] This method seems to be
very sensitive and specific in diagnosing CD, and the presence of
these autoantibodies reinforces the diagnosis in borderline cases,
mainly in seronegative CD [22–24].
Data about the usefulness of these new techniques in
determining when lymphocytic enteritis is CD are scarce and
have been limited to patients with positive serology.[6,22,25]
However, it is well known that the sensitivity of celiac serology in
Marsh type 1 lesion is low, [3,8,26,27] and that when positive, a
diagnosis of CD is generally definitive. To our knowledge, the
reliability of IEL pattern analysis by flow cytometry in seroneg-
ative lymphocytic enteritis has not been investigated, and these are
the challenging cases for CD diagnosis.
The aim of the present study was to evaluate prospectively the
diagnostic accuracy of both CD IEL cytometric pattern analysis
and anti-TG2 IgA subepithelial deposits for diagnosing CD in the
form of both Marsh 3 and 1 lesions with positive serology. In
addition, we assessed the usefulness of these parameters for
diagnosing CD in patients with seronegative lymphocytic enteritis.
Patients and Methods
Patients and controls
Two-hundred and five consecutive patients (144 females; mean
age, 29.361.3 years, range 1–79 years) who underwent small
intestinal biopsy under clinical suspicion of CD and positive HLA
genotyping (see below) were prospectively included in the period
May 2010–December 2012. Clinical presentation is shown in
Table 1. Fifty patients showed villous atrophy (Marsh classification
type 3a, n = 5; and type 3b–c, n = 45) and received a diagnosis of
CD on the basis of the rule of ‘4 of 5’ described by Catassi and
Fasano [28]. Seventy patients showed architecturally normal small
intestinal mucosa with an increase in IEL counts (lymphocytic
enteritis, Marsh type 1 lesion): in 12 of them CD was suspected
because of positive celiac serology, in 15 it was secondary to
Helicobacter pylori infection, and in 43 the etiology of lymphocytic
enteritis was unknown at inclusion. A clinical and histological
response to eradication therapy was required to consider
Helicobacter pylori as the cause of the enteritis. Eighty-five patients
showed normal small intestinal mucosa; 8 of them had positive
celiac serology.
The healthy control group consisted of 10 patients (8 women,
39.765.9 years, range 18–70 years) without CD (normal duodenal
histology and negative celiac serology and HLA-DQ2/8). Eight
additional patients with non-celiac villous atrophy were included
as a disease control group. In these patients, atrophy was
considered to be secondary to olmesartan use (4), collagenous
sprue associated with collagenous colitis (1), ileal Crohn’s disease
(1), or autoimmune disease-associated enteropathy (2). In all of
them celiac serology was negative and there was no response to a
gluten-free diet (GFD).
Patients with intake of non-steroidal anti-inflammatory drugs in
the month previous to the endoscopy or with intestinal parasitic
infection were excluded.
In all patients and controls sample biopsies from the 2nd–3rd
portions of the duodenum for both IEL flow cytometry and
intestinal deposits of anti-TG2 IgA antibodies were obtained in the
index endoscopy.
The protocol was approved by the Ethics Committee of the
Hospital Universitari Mutua Terrassa and all participants (or their
parents in case of less than 16 years old) provided informed
consent.
Flow cytometry
One single duodenal biopsy was obtained using a 2.8 mm
biopsy forceps (Radial Jaw 4, Boston Scientific, USA), and
immediately processed as previously described with minor
modifications.[11,20] Preparations of IEL suspensions were made
by incubation with 1 mM EDTA, 1 mM DTT in HBSS for
90 minutes with continuous rotation at 12 rpm in a vertical shaker
at room temperature. This procedure achieves total removal of
villous epithelium and partial removal of crypt epithelium. The
proper separation of epithelial compartment was confirmed by
immunohistochemical analysis of the remaining tissue during the
protocol validation. The obtained suspension, a mixture of IEL
and epithelial cells, was washed once in fresh HBSS at 1500 rpm
for 10 minutes, and IEL were immediately stained with previously
titrated amounts of directly labeled antibodies for 15 minutes at
room temperature. The antibodies used to define the different IEL
subsets were anti-CD45-APC (clone 2D1), anti CD3-PerCP (clone
SK7), anti CD103-FITC (clone Ber-ACT8) and anti-TCRcd-PE
(clone 11F2) (all from BD Biosciences, Franklin Lakes, NJ, USA).
Intraepithelial origin of the IEL suspension was verified with
CD103+ staining, and it was always $85%. Cells were immedi-
ately analyzed on a standard 4-color FACSCalibur instrument
(BD Biosciences, Franklin Lakes, NJ, USA). Cell counts of the
recovered cell number per biopsy were made with a hemocytom-
eter and trypan blue exclusion. The average number of recovered
IELs from one fresh biopsy was 353,258613,841
(270,773622,503 in patients with atrophy and 398,803624,403
in those without atrophy).
Results were obtained 3 to 4 hours after biopsy sampling, and
were expressed as percentages over bright CD45 staining and low
sideward scatter gate (Figure 1). The normal cut-off values for the
IEL cytometric pattern in our laboratory are CD3+cd+ IEL ,
8.5% (,mean+2SD) and CD32 IEL .10% (.10th percentile).
This cut-off was calculated in a sample of 65 non-celiac subjects.
The intra-assay coefficient of variation is 5.5% (two replicates of
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each sample processed one immediately after the other), and the
inter-sample coefficient of variation is 7.7% (two different samples
from each patient obtained in the same procedure). Figure 1 shows
the four cytometric patterns obtained. The complete CD
cytometric pattern (Figure 1 C) was defined as TCRcd$8.5%
and CD3–#10%, whereas a selective increase of TCRcd was
considered as an incomplete CD cytometric pattern (Figure 1 D).
Intestinal deposits of anti-TG2 IgA antibodies
Biopsies were processed as previously described.[22–24] The
evaluation of anti-TG2 IgA deposits was blindly performed on two
occasions by two experienced observers, considering the pattern
and the intensity of the staining as described.[24] In the non-
concordant readings the highest intensity was considered. Figure 2
shows the immunofluorescence (IF) staining of intestinal deposits
of anti-TG2 IgA antibodies in illustrative cases. A positive IF
staining of anti-TG2 IgA deposits was considered as a CD IF
pattern based on its high accuracy for CD diagnosis.[24] The
degree of intra-observer and inter-observer concordance for
positive deposits (low or high intensity) between the two anti-
TG2 readings was substantial (Kappa = 0.75; 95% CI, 0.66 to
0.85; and Kappa = 0.79; 95% CI, 0.6–0.99, respectively).
Celiac serology
Serum IgA-tissue transglutaminase antibody (anti-TG2) (or IgG
anti-TG2 in IgA deficient patients) was analyzed in serum using a
quantitative automated ELISA detection kit (Elia CelikeyTM,
Phadia AB, Freiburg, Germany) with recombinant human TG2 as
antigen. A value of anti-TG2,2 U/mL was established as the cut-
off limit for normality.[29] Serum IgA anti-endomisial antibodies
(EmA) were examined, as previously described, [30] in patients
with anti-TG2 values ranging from 2 to 8 U/mL in order to
confirm their positivity. Values above 30 U/mL were considered
as high titers of anti-TG2. Total serum IgA was measured using
rate nephelometry (BN II, Siemens Healthcare Diagnostics SL,
Marburg, Germany).
HLA genotyping
Genomic DNA from whole blood was purified using commer-
cial Qiamp DNA Blood Mini kit (Qiagen, Düsseldorf, Germany).
A commercial reverse hybridization kit for the detection of CD
heterodimers HLA-DQ2 (A1*0501/*0505, B1*0201/*0202) and
HLA-DQ8 (A1*0301, B1*0302) was used (GenID, GMBH,
Strasburg, Germany). HLA-DQ2 haplotype is present in 24% of
healthy controls and 90% of CD patients in our geographical
area.[31] In the present study, positive celiac genetics indicates the
presence of HLA-DQ2 (n = 145), HLA-DQ8 (n = 39), or HLA-
DQ2 and DQ8 (n = 8). Some patients with only one allele of the
HLA-DQ2 haplotype, either DQA1 (n = 3) or DQB1 (n = 10),
were also included.
Histological studies
Four endoscopic biopsies of the duodenum were processed
using hematoxylin/eosin staining and CD3 immunophenotyping.
Lymphocytic enteritis (Marsh type 1 lesion) was defined as 25 or
more IEL per 100 epithelial nuclei along with normal villous
architecture, as suggested in recent literature.[2,3] IEL counts
were performed as previously described.[3] Helicobacter pylori
infection was investigated in gastric antral mucosal samples with
standard histopathology assessment [32].
‘Gold standard’ for CD diagnosis
Suspicion of CD arose on the basis of a suggestive clinical
picture and a positive genetic celiac study. The ‘gold standard’ in
diagnosing a patient with CD was applied using the rule of ‘4 of 5’
described by Catassi and Fasano.[28] In this sense, villous atrophy
or lymphocytic enteritis with positive serum anti-TG2 was
considered as CD (titers between 2 and 8 U/mL were considered
as positive only if confirmed by positive EmA).
Statistical analysis
Results are expressed as mean (SEM) or as proportions (and
their 95% confidence interval (CI) when appropriate). Diagnostic
accuracy for CD diagnosis of intestinal IEL flow cytometry and
anti-TG2 IgA intestinal deposits was calculated based on the
following circumstances: 1) Presence of complete IEL cytometric











Classical celiac disease* 12 (24%) 0 (0%) 1 (1.2%) 13 (6.3%)
Diarrhea 7 (14%) 21 (30%) 41 (48.2%) 69 (33.6%)
Dyspepsia 4 (8%) 18 (25.7%) 6 (7%) 28 (13.7%)
IBS symptoms 2 (4%) 12 (17.1%) 9 (10.6%) 23 (11.2%)
Iron-deficiency anemia 9 (18%) 11 (15.7%) 11 (13%) 31 (15.1%)
Growth failure 8 (16%) 0 (0%) 7 (8.2%) 15 (7.3%)
Abdominal pain 7 (14%) 6 (8.5%) 11 (13%) 24 (11.7%)
Asymptomatic – First degree relative 7 (14%) 6 (8.5%) 7 (8.2%) 20 (9.7%)
Organ-specific autoimmune disease 2 (4%) 0 (0%) 6 (7%) 8 (3.9%)
Systemic autoimmune disease 1 (2%) 3 (4.3%) 1 (1.2%) 5 (2.4%)
Increased level of liver enzymes 3 (6%) 3 (4.3%) 0 (0%) 6 (2.9%)
Microscopic colitis 1 (2%) 0 (0%) 1 (1.2%) 2 (0.9%)
Other 0 (0%) 0 (0%) 2 (2.4%) 2 (0.9%)
*Digestive symptoms and weight loss or growth failure.
doi:10.1371/journal.pone.0101249.t001
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CD pattern (TCRcd$8.5% and CD32#10%); 2) Presence of
incomplete IEL cytometric CD pattern (TCRcd$8.5%); 3)
Presence of positive subepithelial deposits of anti-TG2 (IF CD
pattern); and 4) Presence of both TCRcd$8.5% and positive
subepithelial deposits of anti-TG2 (combined incomplete cyto-
metric/IF pattern). Sensitivity, specificity, positive predictive value
(PPV), and negative predictive value (NPV) for CD diagnosis were
computed on 262 tables. Patients fulfilling ‘‘4 of the 5’’ criteria for
CD were considered as true positives (n = 60), whereas patients
with non-celiac atrophy (n = 8) and patients with lymphocytic
enteritis secondary to Helicobacter pylori (n = 15) were considered as
true negatives.
McNemar test was used to assess differences in test sensitivity
and specificity between the different tests. One-way analysis of
variance was used for comparison of quantitative variables. As
post-hoc tests to assess differences among groups, either the
Bonferroni test for homogeneous variances or the Tamhane test
for the non-homogeneous ones were used. Kappa coefficient was
Figure 1. Representative flow cytometry dotplots of the 4 patterns. Left: TCRcd+ T cells; Right: CD32 cells. Non-celiac patterns: A, Normal
pattern; and B, Decrease of CD32 cells. Celiac patterns: C, Increase of TCRcd+ T cells plus decrease of CD32 cells; and D, Increase of TCRcd+ T cells
only.
doi:10.1371/journal.pone.0101249.g001
Diagnosis of Celiac Lymphocytic Enteritis
PLOS ONE | www.plosone.org 4 July 2014 | Volume 9 | Issue 7 | e101249
calculated as a measure of degree of concordance between the two
readings of anti-TG2 IgA intestinal deposits. All statistics were
generated using the SPSS for Windows statistical package (SPSS
Inc., Chicago, IL, USA).
Results
Discrimination potential of intestinal intraepithelial
lymphocyte flow cytometry and intestinal deposits of
anti-TG2 IgA
The CD IEL cytometric patterns using the cut-offs described
above are shown in Figure 1 (see patients and methods section).
IEL cytometric pattern in Marsh 3 and Marsh 1 patients with
Figure 2. Intestinal deposits of anti-TG2 IgA. Immunofluorescence staining of IgA (green) and TG2 (red). Colocalization of IgA and TG2 is shown
in orange-yellow. A: Normal histology patient with no deposits. B: Marsh 1 patient with mild staining around crypts. C: Marsh 3 patient with intense
subepithelial deposits.
doi:10.1371/journal.pone.0101249.g002
Figure 3. Comparison of IEL pattern between healthy controls, Marsh 3 patients and Marsh 1 patients with positive serology
(serum anti-tTG2). In all cases p,0.001, representing the differences between Marsh 3 and Marsh 1 vs. control group.
doi:10.1371/journal.pone.0101249.g003
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positive serum anti-TG2 and controls is shown in Figure 3 and
Table 2. CD45+ IEL percentage was not sensitive enough to
separate CD Marsh 3 and Marsh 1 from healthy controls. By
contrast, TCR cd+ and CD32 cells allowed an excellent
discrimination between patients and controls.
There were no significant differences in the mean value of
CD45+, TCR cd+ and CD32 cells between children (,14 years)
and adults (data not shown).
Regarding intestinal deposits of anti-TG2 (CD IF pattern)
(Figure 2), non-concordant readings between the two evaluations
performed occurred in 8 patients with normal histology, 9 patients
with lymphocytic enteritis, and 5 patients with villous atrophy.
Two of the 10 healthy controls (20%; CI, 5.6% to 50%) with
negative HLA-DQ2/8 haplotypes showed low intensity positive
deposits with agreement of the two observers.
Diagnostic accuracy of CD IEL cytometric and IF pattern
Accuracy of the studied parameters for the diagnosis of CD in
patients with positive serum anti-TG2 (Marsh 3 plus Marsh 1
lesions) is described in Table 3. We found that the highest
sensitivity for CD diagnosis was achieved by the presence of an
incomplete IEL cytometric pattern (97%), whereas both the
complete CD IEL cytometric pattern and the combined incom-
plete/IF pattern had 100% specificity. Consequently, these criteria
found to be highly specific for CD diagnosis were further applied
to the diagnosis of patients with villous atrophy and lymphocytic
enteritis.
Two of the patients with non-celiac villous atrophy secondary to
olmesartan use and unresponsive to a GFD had either an increase
in TCRcd+ IEL or anti-TG2 intestinal deposits; in addition, 3 of
the 15 patients with lymphocytic enteritis secondary to Helicobacter
pylori had one of the CD related parameters positive (2 anti-TG2
intestinal deposits and 1 increase in TCRcd+ IEL).
Patients with villous atrophy
Fifty of the 205 patients had villous atrophy. All of them fulfilled
the ‘gold standard’ for CD diagnosis, 48 at baseline (i.e., before
starting a GFD) and the remaining 2 after achieving a complete
response to a GFD (flow chart in Figure 4A). Serum anti-TG2 IgA
was positive in 48 of the 50 patients (44 at high titers and 4 at low
titers). The CD cytometric pattern was present in 48 of the 50
patients (44 complete and 4 partial). In addition, a positive CD IF
pattern was present in 48 of the 50 patients. Therefore, the
simultaneous presence of the 3 analytical parameters, highly
specific for CD diagnosis (serology, anti-TG2 intestinal deposits
and complete IEL cytometric pattern), was found in 41 of the 50
CD patients with atrophy. In the remaining 9 patients at least one
of these parameters was present showing their complementary
value.
Patients with lymphocytic enteritis
Seventy of the 205 patients had lymphocytic enteritis, 12 of
them with positive serum anti-TG2 IgA. In Table 2 and Figure 5,
results of IEL flow cytometry of patients with lymphocytic enteritis
as compared to controls are provided. Seronegative CD Marsh 1
patients showed a significant increase in mean TCRcd+ IEL as
compared to healthy controls and non-CD Marsh 1, but the values
were not as high as in CD Marsh 1 with positive serology. By
contrast, the mean percentage of CD32 was identical in CD
Marsh 1 irrespective of whether they had positive serology or not
and was significantly lower than in healthy controls.
Table 2. Mean (6SEM) values of CD3+TCRcd+ and CD32 intraepithelial lymphocytes in the different subgroups of patients with














(n = 43) p
CD3+TCRcd+ (%) 4.160.7 26.561.5a 31.465.1a 16.661.9a b 3.660.3 ,0.001
CD32 (%) 23.763.5 4.160.5c 7.461.9c 7.561.4c 11.761.1b ,0.001
ap,0.05 vs Healthy controls and Non-CD Marsh 1;
bp,0.05 vs CD Marsh 3;
cp,0.05 vs Healthy controls.
doi:10.1371/journal.pone.0101249.t002









Complete FCP** 85 (73–92.5) 100 (82–100) 100 (91–100) 72 (53–86)
Incomplete FCP** 97 (87–99)a,b 91 (70–98.5) 97 (87.5–99) 91 (70.5–98.5)
IF pattern** 92 (80–97) 87 (65–96.5) 95 (85–99) 80 (59–92)
Incomplete/IF pattern** 88 (77–95) 100 (82–100) 100 (91–100) 77 (57–89)
*Cases: 48 CD atrophy and 12 CD lymphocytic enteritis with positive serum anti-TG2; Controls: 8 non-CD atrophy and 15 lymphocytic enteritis secondary to Helicobacter
pylori infection.
**Complete FCP: Complete CD IEL flow cytometric pattern (FCP): TCRcd$8.5% and CD32#10%; Incomplete FCP: Incomplete CD flow cytometric pattern (FCP): isolated
TCRcd increase ($8.5%).
IF pattern: CD pattern of immunofluorescence showing intestinal deposits of anti-TG2 IgA; Incomplete/IF pattern: Incomplete FCP plus IF pattern.
ap = 0.06 vs Incomplete/IF pattern;
bp = 0.015 vs Complete FCP.
doi:10.1371/journal.pone.0101249.t003
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The routine immunochemistry anti-CD3+ IEL counting by the
pathologist showed no significant differences in the different
groups of patients with lymphocytic enteritis (Seropositive CD:
37.664.9%; Seronegative CD: 36.563.1%; Helicobacter pylori
lymphocytic enteritis: 36.763.4%; other lymphocytic enteritis:
36.262%; p = 0.99).
Positive serum anti-TG2. All 12 patients fulfilled the ‘gold
standard’ for CD (flow chart in Figure 4B; Table 4). Three of them
had high titers of anti-TG2, 6 had low titers, and 2 had titers
between 2 and 8 U/mL confirmed by EmA+; 1 patient with IgA
deficiency had positive serum anti-TG2 IgG. The CD cytometric
pattern was observed in 12 patients (9 complete and 3 incomplete
pattern), and the CD IF pattern was observed in 8.
Negative serum anti-TG2. Eight of the 58 patients with
negative celiac serology fulfilled the ‘gold standard’ for CD since
they had a good response to a GFD (flow chart in Figure 4B;
Table 4). Seven of these patients had a CD cytometric and/or IF
pattern; in the remaining patient serum EmA was detected and the
IEL flow cytometry evolved to a complete CD cytometric pattern
during follow-up.
In 7 additional patients CD was suspected since they presented
the complete CD cytometric pattern and one of them also the CD
IF pattern. However, the effect of a GFD could not be assessed in
Figure 4. Flow diagnostic charts showing the presence of serum anti-TG2 (TGs), the complete CD IEL cytometric pattern (CP), an
isolated increase of CD3+TCRcd+ (incomplete CD cytometric pattern), and intestinal deposits of anti-TG2 IgA (TGd; CD IF pattern) in
the studied population: A. CD villous atrophy; and B. Lymphocytic enteritis. Response to GFD is described when appropriate to fulfill the
‘gold standard’ (rule ‘4 of 5’).
doi:10.1371/journal.pone.0101249.g004
Figure 5. Comparison of CD IEL pattern between control group (A), seropositive CD Marsh 1 (B), seronegative CD Marsh 1 (C),
lymphocytic enteritis secondary to Helicobacter pylori infection (D), and lymphocytic enteritis of unknown etiology (E). IEL CD3+cd+:
p,0.001, groups B and C vs. other groups; IEL CD32: p,0.001, groups B and C vs. control group.
doi:10.1371/journal.pone.0101249.g005
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any of them (see Table 4). They were considered as ‘probable CD’
based on the high specificity of the complete CD cytometric
pattern.
Forty-three patients were considered to have non-celiac
lymphocytic enteritis. Two of them had a mild increase of
TCRcd+ IEL and three low-intensity positive anti-TG2 deposits.
Overall, the IEL flow cytometric pattern identified at baseline
19 of the 20 Marsh 1 patients who fulfilled the ‘gold standard’ for
CD either at inclusion or after GFD, whereas both IF pattern and
serology detected only 12 of them (95% vs 60% vs 60%; p = 0.039).
Patients with normal histology
Eighty-five of the 205 patients had normal histology. Twelve of
them had at least one of the three parameters found to be highly
specific for CD. Eight had positive serology (7 with CD IEL
cytometric pattern, 6 with CD IF pattern), 2 the complete CD IEL
cytometric pattern and another 2 the combined incomplete IEL
cytometric/IF pattern. These 12 patients were considered to have
latent CD, with half of them being first degree relatives.
Twenty-two additional patients presented with only one celiac
parameter: incomplete cytometric pattern in 17 and isolated IF
pattern in 5. Nine of these 22 patients were first degree relatives of
CD patients.
The cytometric values of the different subgroups of Marsh 0
patients as compared with healthy controls are provided in
Table 5. As may be seen, there was a significant increase in mean
TCRcd+ IEL in latent CD as compared to healthy controls and
non-CD Marsh 0, without significant changes in mean CD32
values. Values in non-CD Marsh 0 were very similar to those in
healthy controls.
Discussion
Differential diagnosis of lymphocytic enteritis is difficult, since
multiple etiologies have been proposed for this condition [3–5].
Most patients have unspecific clinical symptoms, and a work-up to
rule out CD is necessary. A low percentage of these patients have
positive celiac serology, [3,26,27,33] and others may progress to
villous atrophy with positive serology after a gluten chal-
lenge.[5,34] Both situations indicate that CD is a possibility to
be considered. In most cases, however, the diagnosis of CD is
obtained in seronegative patients with positive HLA-DQ2/DQ8
after showing a gluten dependence in both clinical symptoms and
histology.[3] In spite of this, a diagnosis of CD frequently remains
uncertain since the effect of a GFD on clinical symptoms is non-
specific and lymphocytic enteritis may resolve spontaneously.[5]
To further complicate this scenario, it has been recently reported
that patients with non-celiac gluten sensitivity may have lympho-
cytic enteritis.[35] Therefore, tests to clearly differentiate celiac
and non-celiac lymphocytic enteritis are needed.
In this setting, results of the present study suggest that the CD
IEL cytometric pattern mainly disclosing an increase in TCRcd+
IEL may be a useful tool for reinforcing the diagnosis of CD. The
concomitant decrease in CD32 IEL as well as the presence of
anti-TG2 intestinal deposits adds specificity for the CD diagnosis.
Our results confirm the high diagnostic accuracy of both CD IEL
cytometric and IF patterns in patients with atrophy and positive
celiac serology, as suggested in the literature.[6,11,24,36] These
parameters were, in general, not necessary for CD diagnosis in
patients with atrophy. However, the CD IEL cytometric pattern
may be helpful in selected clinical situations such as cases with
atrophy secondary to other etiologies. In this sense, in the present
study 7 out of 8 seronegative patients with atrophy due to a variety
of etiologies showed normal IEL pattern and negative deposits,
and only 1 of these patients had an isolated increase in TCRcd+
IEL without response to a GFD. Since atrophy cases in Western
countries are generally due to CD, it is important to have
complementary diagnostic tests to definitely rule out this diagnosis
in doubtful cases with negative serology.
After the validation of the diagnostic usefulness of these
parameters in patients with positive serology, we used them to
categorize all included patients with lymphocytic enteritis as CD
or not, on the basis of the 100% specificity for CD diagnosis of
both the complete CD IEL cytometric pattern and the combined
incomplete cytometric/IF pattern. This allowed us to observe that
CD IEL cytometric pattern was more useful than both routine
celiac serology and CD IF pattern for identifying CD in patients
with lymphocytic enteritis. This methodology allowed us to
establish the diagnose of CD in almost 40% of the patients with
lymphocytic enteritis consecutively included in the present series,
selected on the basis of clinical symptoms and positive celiac
genetics. This is more than twice the number of patients diagnosed
on the basis of serological results alone.
Results show that IEL subset assessment by flow cytometry was
a reliable procedure with intra-assay and inter-sample coefficients
of variation reflecting good performance on the test. Mean values
of TCRcd+ and CD32 cells observed in both the control group
and patients with CD atrophy are very similar to what was
Table 4. Usefulness of both IEL flow cytometric pattern and IF pattern for the diagnosis of CD in patients with lymphocytic
















Complete FCP 9 4 7 0 13 (65%)**
Incomplete FCP 3 3 0 2 6 (30%)**
IF pattern 8 4+ 1 3 12 (60%)
Incomplete/IF pattern 1 2 0 0 3 (15%)
FCP: Flow cytometric pattern.
*A GFD could not be started in 3 patients (1 not accepted, 2 non-symptomatic first degree relatives); Response to a GFD not evaluable in 4 patients (2 lost in follow-up, 2
with associated psychiatric disorders).
+1 patient with an isolated CD IF pattern at inclusion developed positive EmA and the complete CD cytometric pattern in a follow-up duodenal biopsy.
**Positive FCP (65%+30% = 95%) vs positive IF pattern (60%), p = 0.039 (McNemar Test).
doi:10.1371/journal.pone.0101249.t004
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previously described using the same methodology.[13,20] The cut-
off selected to define normal values was different from previous
studies.[14,37] In the first one the methodology was different since
the entire biopsy specimen was homogenized and processed. In
the second study, the IEL fraction was isolated as in the present
study, but the cut-off used for TCRcd+ was higher (,15%). The
most likely explanations for this are differences in both the patients
evaluated (Marsh 3 vs Marsh 1) and the selection criteria of the
control group. In the present study, very strict criteria to select
subjects for the control group were used to rule out latent celiac
disease. Further, the mean TCRcd+ value in CD Marsh 1 with
negative serology was lower than in CD patients with positive
serology, reinforcing the use of a lower cut-off to separate them
from controls.
A normal IEL cytometric pattern was observed in control
subjects and most of the patients with either non-celiac villous
atrophy or Helicobacter pylori-associated lymphocytic enteritis,
similar to what has been described in the literature.[11,12,20,39]
In fact, the presence of the complete CD cytometric pattern was
associated with 100% specificity for CD diagnosis. Finally,
sensitivity of TCRcd+IEL increase for CD atrophy and CD
lymphocytic enteritis was 97% and 95%, respectively. These
figures are higher than those reported in the literature for the
immunohistochemistry assessment of cd+IEL to detect either CD
atrophy or mild enteropathy CD in patients with positive serology.
Those figures were 91–94% and 74–84%, respectively.[7] In
addition, evaluation of cd+IEL by immunohistochemistry in non-
celiac controls is quite unspecific, yielding 18–23% positive
results.[6,36] In contrast, the present data and data from the
literature suggest that the false-positive rate for cd+IEL evaluation
by flow cytometry is very low.[11,12,20,38] Although further
studies directly comparing the two techniques for evaluating cd+
IEL will be welcomed, the present data suggest that flow cytometry
should be the preferred procedure to assess the cd+IEL
populations.
Anti-tTG2 IgA intestinal deposits fared worse than IEL
cytometric pattern for detecting CD in patients with lymphocytic
enteritis. It has to be taken into account that non-concordant
results with the first reading negative and the second reading
positive were considered as positive for the present study, which
increased the positive result rate. Likewise, the reading of anti-
tTG2 deposit plates was associated with some degree of
subjectivity, and it lacked specificity. In this sense, the intra- and
inter-observer concordance rates were substantial but not excel-
lent, and 20% of control subjects without CD presented with
positive deposits considered as false-positives. Previous studies
showed excellent intra-observer and inter-observer concordance
for the detection of anti-TG2 intestinal deposits, [6,24] but non-
celiac control subjects also presented positive mucosal deposits in
12 to 20% of cases.[6,24,36] The diagnostic yield observed in
lymphocytic enteritis seems to be similar to or even worse than the
diagnostic accuracy of the anti-tTG2 assay of the culture medium
of biopsy specimens.[25,26,39] A recent study comparing the two
techniques suggested that the measurement of antibodies secreted
into culture supernatant is the best method for detecting intestinal
anti-tTG2 antibodies [25].
A small subgroup of patients with positive celiac genetics and
normal histology presented with highly specific CD parameters,
half of them being first degree relatives of patients with CD,
suggesting that they have latent CD, as has been previously
described in the literature.[10,11] There was another subgroup of
these patients who presented with only one celiac parameter,
either an increase in TCRcd+ IEL or positive anti-TG2 deposits,
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leading to uncertain interpretation since a false positive result
cannot be ruled out.
In conclusion, the analysis of IEL flow cytometric pattern is a
fast, accurate method for identifying CD in the initial diagnostic
biopsy of patients presenting with lymphocytic enteritis. In
addition, it also allows detection of latent CD in subjects with
normal histology. The diagnostic reliability of this test seems to be
greater than that of the evaluation of anti-TG2 IgA intestinal
deposits. Study highlights are described in Table 6. Further studies
will be needed to confirm the accuracy of the CD cytometric
pattern for the diagnosis of CD in patients with lymphocytic
enteritis.
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support; and to Núria Rubies, Maite Roldan, Olga Benı́tez, Anabel Polo,
and Rosa Tomás for their helpful technical assistance.
The ‘Centro de Investigación Biomédica en Red de Enfermedades
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genética, aspectos clı́nicos y poblaciones de riesgo. Doctoral Thesis. University of
Barcelona.
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